Mar 16 2021🔹Last minute - Mayor of Catania asks: Pfizer to start production in Catania branch too

Today Mar 16 2021 🔹 Last minute - Mayor of Catania asks: Pfizer to start production in Catania branch too

MEDICINE 🔹The Pfizer Branch of Sicily in the center of the Mediterranean has the professionalism necessary to make a breakthrough in the fight against the virus.
- The Mayor of Catania - invites the top management of Pfizer: - we are ready to offer any institutional support necessary to achieve in a very short time a pole for the development and manufacture of vaccines in Catania - to make a concrete contribution in the fight against Covid, enhancing the potential of the Pfizer branch in Catania.

🔹
Il Sindaco di Catania - Etna East Sicily - Salvo Pogliese - ha diffuso un comunicato dove invita i Vertici aziendali internazionali Pfizer a produrre il vaccino antiVirus anche nel sito esistente da molti anni in Catania.

🔹CATANIA - puo essere occasione per i vertici aziendali della Pfizer ad attivare gli investimenti necessari per produrre, anche nello stabilimento di Catania, i vaccini antivirus necessari per avviare una campagna di inoculazione proficua e rapida.

🔹La Filiale Pfizer di Sicilia al centro del Mediterraneo ha le professionalità necessarie per imprimere una svolta nella lotta al virus.
- Il Sindaco di Catania - invita i vertici della Pfizer: - siamo pronti ad offrire ogni supporto istituzionale necessario per realizzare in tempi brevissimi un polo per lo sviluppo e la fabbricazione di vaccini a Catania - per dare un contributo concreto nella lotta al Covid, valorizzando le potenzialità della filiale Pfizer - di Catania


🔹 /// Pfizer HISTORY /// IN CATANIA 🔹


🔹🔹🔹 🔹1° gruppo farmaceutico & biofarmaceutica al mondo per giro d’affari e 3° per capitalizzazione.

➤🔹Pfizer - tra le grandi case farmaceutiche produttrici di vaccini, conosciuta dal grande pubblico perché 1a a commercializzare il Viagra - la pillola blu della virilità maschile.
🔹Pfizer presente in ITALIA con 3 stabilimenti: Catania - Aprilia - Ascoli
Stabilimento Pfizer a CATANIA in zona Industriale

➤ 🔹 Numeri dello stabilimento Pfizer a CATANIA🔹
Realizzato nel 1959 🔹Recentemente potenziato il suo ruolo in produzione di farmaci iniettabili sterili anche generici
🔹Superficie di 200 mila mq. di cui circa 45.000 coperti suddivisi in area di produzione farmaceutica per Uomo.
🔹Forme farmaceutiche: iniettabili sterili
🔹Specializzato in produzione di antibiotici parenterali di 1a linea per uso ospedaliero, penicillinici e non penicillinici

🔹Volume di produzione: circa 26 ML tra flaconi e siringhe


🔹 Pfizer HISTORY WORLD 🔹
PFIZER AND BIONTECH ACHIEVE FIRST AUTHORIZATION IN THE WORLD FOR A VACCINE TO COMBAT
🔹 🔹 NEW YORK & MAINZ, Germany

🔹 🔹 Dec 2 2020 🔹 Pfizer and BioNTech Achieve First Authorization in the World

🔹 🔹 In the shadow of Mount Etna on Sicily's east coast, Pfizer Global Supply's production facility in Catania is harnessing the power of the sun in a big way.

🔹 Mar 2021 - The European Union will receive an extra 4 million 🔹 🔹 🔹 🔹 Pfizer and BioNTech vaccine doses over the next 2 weeks to be deployed to Covid-19 hotspots, European Commission chief Ursula von der Leyen said on Wednesday.
The delivery - over and above already agreed supplies from the vaccine-maker - will go to affected border regions within the bloc to help ensure or restore free movement of goods and people, she said in a statement.
🔹 The announcement came as the commission attempted to persuade at least 6 member States - including her home country Germany - to lift virus-related border restrictions deemed by Brussels to be excessive.

🔹 The company wants to produce 250 million jabs in the first half of 2021🔹

🔹 Mar 2021 - 🔹 Pfizer and BioNTech starts vaccine production🔹 🔹 🔹 at new site in Marburg Germany 🔹 🔹
Vaccine developer BioNTech has launched production of the COVID-19 vaccine it developed with US giant Pfizer at a new plant in the German town of Marburg.
The facility could significantly boost the EU's vaccine supply.

Mar 2021 🔹BioNTech inizia la produzione di vaccini in un nuovo sito in Germania - Perchè no in Sicilia ?

Lo sviluppatore di vaccini BioNTech ha lanciato la produzione del vaccino COVID-19 che ha sviluppato con il gigante americano Pfizer in un nuovo stabilimento nella città tedesca di Marburg.
🔹 La nuova fabbrica tedesca potrebbe aumentare significativamente la fornitura di vaccini in Unione Europea.


🔹 Pfizer HISTORY in Unione Europea 🔹

The main EU plant for production of the vaccine is Pfizer's factory in Puurs, Belgium.
BioNTech plans to produce up to 250 million doses of the COVID-19 vaccine in Marburg in the first half of 2021.

EMA 🔹 European Medicines Agency (EMA) is expected to carry out its first quality checks on the medical products from the site in February or March.
The first vaccines produced at the Marburg site are expected to be delivered at the beginning of April, BioNTech said.

🔹 Trouble with the EU
BioNTech announced in mid-January that shipments of the jabs for the EU would be delayed because of necessary modifications at the Puurs factory.
🔹The news took the bloc - now under fire over its sluggish vaccine rollout - by surprise.
The company said in early February it would meet its contractual commitments for the first quarter and pledged to send up to 75 million extra doses to the EU in the spring.


🔹 Pfizer and BioNTech 🔹

🔹Brussels has ordered a total of 600 million doses of the so-called Comirnaty vaccine from BioNTech and Pfizer.

🔹BioNTech said it expected the site in Marburg, some 75 km (almost 50 miles) north of Frankfurt, to become one of the largest mRNA manufacturing sites in Europe.
🔹The expected annual production capacity, it said, would be 750 million doses.

🔹To ramp up the scope for vaccine production, 🔹 Pfizer and BioNTech bought the Marburg plant from Swiss drugs giant Novartis last year.
It retained some 300 employees already working there.

Read more links

🔹 Pfizer
www.pfizer.com

Contacts:🔹Media Relations
Andy Widger
+44 7970 149098
andrew.widger@pfizer.com

🔹Investor Relations: Chuck Triano
+1 (212) 733-3901
Charles.E.Triano@Pfizer.com

BioNTech Contacts:🔹Media Relations
Jasmina Alatovic
+49 89 62 81 75 46
Media@biontech.de

Investor Relations🔹Sylke Maas, Ph.D.
+49 (0)6131 9084 1074
Investors@biontech.de


🔹 🔹 Read more links
www.sicilydistrict.eu/news/medicine-sanita/pfizer-quella-di-vaccino-antivirus-10148-in-stabilimento-di-catania-200-posti-di-lavoro-in-bilico/10924

🔹 🔹
www.sicilydistrict.eu/eventi/the-first-consignment-of-the-pfizer-biontech-in-malta/21868

Alpiz
🔹 🔹

BE The First To Know about HEALTH - Medicine Pharmevolution Chi in - dove . . who 🔹 Inside our N 1 TOP HEALTH - Medicine website www.SicilyDistrict.eu
🔹 🔹🔹🔹🔹

---